DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway
Qing Lu, Xiaobao Chen, Zhenlin Chen, Jing Lin, Yiming Su · 2026
Read DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway by Qing Lu, Xiaobao Chen, Zhenlin Chen, Jing Lin, Yiming Su (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13657761.txt.
Description
Qing Lu and four co-authors study a gene called DUSP13 in prostate cancer in a 2026 paper. The disease is a leading cause of cancer illness and death in men, and late-stage cases gain little from current drugs.
Genes in this family switch off a growth pathway, and members can either slow or speed tumors depending on context. The team measured DUSP13 in normal prostate cells and in three cancer cell lines. They then silenced the gene in two cancer lines with two separate tools, to rule out off-target effects. Silenced cells were tested for growth, movement, spread, and death, and tumors were grown in mice. Pathway proteins were tracked to see how the gene acts through the ERK route named in the title.
Catalog record
| CREATOR | Qing Lu, Xiaobao Chen, Zhenlin Chen, Jing Lin, Yiming Su |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |